Frontline Axi-Cel Elicits 74% CR Rate in High-Risk Large B-Cell Lymphoma
OncLive,
Axicabtagene ciloleucel (axi-cel; Yescarta) elicited a high objective response rate (ORR) of 85%, with a complete response (CR…
Axicabtagene ciloleucel (axi-cel; Yescarta) elicited a high objective response rate (ORR) of 85%, with a complete response (CR…
1. In a prospective cohort study of 138 patients undergoing the combination of rituximab plus cyclophosphamide, doxorubicin…
(MedPage Today) -- Prognostic role for may be less than expected
Results of a large trial have indicated that the use of interim PET/CT imaging has limited prognostic value to DLBCL patients…